Analyst Report: COHR

1. EXECUTIVE SUMMARY

Coherent rose 13.58% to $192.81 on Friday 6 November, recovering part of a 12.98% fall the session before. The brief points to three drivers: renewed attention on the roughly $20bn PhotonLink agreement, a group-wide bounce in optics names, and a technical rebound after a steep slide, with a Citi target increase also cited by TIKR. The sell-off that preceded it was tied by CNBC, TIKR and Morningstar to fears that the midterm result will slow data-centre build-outs, and the stock-specific worry was cash flow, with operating cash flow of negative $93m and capex of $776m. The stock closed 8.33% below its 30 October level and 38.32% below its close 20 sessions earlier, so Friday's gain leaves most of the recent decline in place. The brief records conflicting accounts of the timing of the results reaction, which is covered below.

2. THE CATALYST

Friday's rebound had no single event behind it. 24/7 Wall St. (6 November) attributed it to investors revisiting the PhotonLink agreement, a five-year deal worth about $20bn with a major AI customer (TradingKey, 4 November), and to a technical bounce after a steep slide. TIKR (6 November) added a Citi target increase and a bounce in optics names including Lumentum, Marvell, Credo and Astera. Peers in electronic components also rose that day, with Corning up 2.61% and Amphenol up 4.12%, against a 0.31% gain in the S&P 500.

The preceding sessions set the context:

Coherent reported fiscal first-quarter results after the close on 4 November (Coherent IR). Revenue was $2.37bn, up 50% year over year (56% pro forma), and non-GAAP EPS was $2.09, up 80%. GAAP gross margin was 39.1%. Guidance for the December quarter was $2.55bn to $2.75bn against $2.54bn expected (TIKR, 5 November).

The 5 November session combined the results reaction with a broad sell-off. Morningstar reported US stocks had their worst day since April 2025 on uncertainty over data-centre development after the midterms. CNBC reported that Democrats secured both the House and Senate, and CNN noted that Texas Governor-elect Gina Hinojosa campaigned on a temporary data-centre moratorium and removing certain tax incentives. Goldman Sachs estimated that short-term moratoria could affect about 45% of planned US data-centre capacity expansion (Morningstar). Ciena and Credo also fell that day (TIKR).

The brief notes that intraday headlines gave a 13.7% to 16% fall for 5 November, which differs from the closing move used here. It also records that no readable source explains the 4 November decline before the release, and that Investing.com headlined a surge after the release that evening.

3. COMPANY PROFILE

Coherent Corp. (Technology, Scientific & Technical Instruments) makes lasers, transceivers and other optical and optoelectronic devices, modules and systems. Its Datacenter and Communications segment sells transceivers, co-packaged optics and optical circuit switches. Market cap is $37.98bn, with a forward P/E of 13.3 and a trailing P/E of 39.9. Peers named in the brief include Lumentum, Marvell, Credo, Ciena and Applied Optoelectronics.

From the 4 November results and call (Coherent IR):

• Management expects its first $3bn revenue quarter by the end of fiscal 2027 and pro forma growth above 60% for the year.
• It expects its first $4bn quarter in fiscal 2028.
• It targets non-GAAP gross margin above 45% in the first quarter reaching that level, before the end of calendar 2028.
• PhotonLink revenue is expected to begin in early calendar 2028 (TradingKey), with more than $100m in the March quarter and above $250m per quarter before the end of calendar 2027 per the call transcript. The brief gives these dates as stated and they differ in timing, so treat the PhotonLink schedule as unsettled.
• Indium phosphide capacity is ahead of schedule, with output planned to more than double by the end of 2027 (Benzinga).

Capex rose to $776m from $556m in the prior quarter (BigGo Finance), and inventory rose to $3.3bn from $2.6bn in June (TIKR).

4. DEEP DIVE ANALYSIS

Do fundamentals justify the move? The results beat on growth and the guidance midpoint sits above consensus. Friday's rebound followed no new company disclosure in the brief, so it fits a sentiment bounce. In my inference, a 13.58% gain on 2.24x average volume after a 12.98% fall reflects traders repositioning more than a change in view of the business.

Valuation. TIKR put the forward P/E at about 21x on 5 November against 57x at the June peak. B. Riley's comment, per TIKR, is that sector multiples follow sentiment on AI funding more than quarterly results. The stock sits 56.2% below its 52-week high of $440.00.

Analyst actions.

MarketScreener (6 November) put the consensus target at about $387.80 across 26 analysts. Citi's change is dated 5 November by MarketScreener and 6 November by Yahoo. Craig-Hallum and JPMorgan target cuts appear undated in StockAnalysis and are excluded.

Sector read-across. Marvell agreed on 2 November to buy Lumentum in an all-stock deal valued at about $115bn (TIKR). 24/7 Wall St. reported that analysts expect a Chinese antitrust review of 12 to 18 months, and that the implied value to Lumentum holders has fallen because Marvell pays in stock. Applied Optoelectronics beat on Q3 but guided Q4 revenue below consensus and said its 2027 US capacity expansion will take longer (24/7 Wall St.). A Bernstein note put the midterm-related capacity hit at 2% to 4%, but its date is unconfirmed. The brief found no other sourced episode that closely matches this one.

Bull case. Guidance above consensus, raised medium-term targets, a $20bn customer agreement, and a CEO who said demand shows no signs of attenuation (24/7 Wall St.). Targets from Stifel, Citi and Rosenblatt remain far above the price.

Bear case. Negative operating cash flow, capex of $776m and inventory up to $3.3bn. Policy risk to data-centre build-outs, with Texas a named focus. PhotonLink revenue starts in 2028 on the brief's account, which leaves a long gap. BofA and B. Riley hold Neutral ratings, and BofA's $240 target is the second-lowest in the brief, after B. Riley's $228.

5. TECHNICAL SNAPSHOT

The $192.81 close sits below the 50-day average of $270.02 and the 200-day average of $296.42, and 47.0% above the 52-week low of $130.42. Within the recent closes, the nearest support is $169.76 from 5 November, and the nearest resistance is $195.09 from 4 November, just above the latest close. Friday's volume of 16,226,300 was 2.24x the 50-session average and close to the prior session's 17,277,200, which shows heavy two-way trading around the low. The stock is down 0.78% year to date.

6. RISK FACTORS

• Policy: state-level data-centre moratoria or tax-incentive changes, with Texas the example in CNN's reporting, and Goldman's 45% exposure estimate.
• Cash: negative operating cash flow and rising capex and inventory.
• Sentiment: sector multiples have compressed from about 57x to about 21x forward earnings on TIKR's figures, and the swings in this window were large in both directions.
• Sector events: the Marvell and Lumentum antitrust review of 12 to 18 months, and weak guidance from Applied Optoelectronics.
• Execution: PhotonLink revenue above $100m in the March quarter, shipments for scale-up applications in the second half of calendar 2027 (Motley Fool transcript), and the capacity ramp.
• Dated catalyst: next earnings on 3 February 2027 (Yahoo estimate), with consensus of EPS $2.37 and revenue $2.54bn.

7. ACTIONABLE OUTLOOK

Short term (1-2 weeks): The stock holds a rebound that recovered only part of the prior two sessions' fall. Price action around $169.76 and $195.09 sets the range, and policy headlines on data-centre build-outs drive the direction. A further sector sell-off would test the 5 November low; continued optics strength would bring the 4 November close into play.

Medium term (1-3 months): Direction depends on sector sentiment toward AI funding and on whether clarity emerges on state data-centre policy. No company earnings fall in this window. Cash flow and inventory data will draw attention at the next report on 3 February 2027.

Long term: The thesis is unchanged on the evidence in the brief. Management raised its medium-term targets, and the PhotonLink agreement and capacity expansion support the growth outlook. The cash-flow profile is the item to monitor. This is analysis only and not personal financial advice.